{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:20:47Z","timestamp":1778811647738,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sever\ufeffe and difficult asthma in a low- and middle-income country (LMIC) can relate to (a) lack of availability of basic medications; (b) potentially reversible factors such as poor adherence or comorbidities such as obesity inhibiting a good response to treatment; and (c) (rarely) true severe, therapy-resistant asthma. However, definitions of severity should encompass not merely doses of prescribed medication, but also underlying risk. The nature of asthmatic airway disease shows geographical variation, and LMIC asthma should not be assumed to be phenotypically the same as that in high-income countries (HICs). The first assessment step is to ensure another diagnosis is not being missed. Largely, political action is needed if children with asthma are to get access to basic medications. If a child is apparently not responding to low dose, simple medications, the next step is not to increase the dose but perform a detailed assessment of what factors (for example co-morbidities such as obesity, or social factors like poor adherence) are inhibiting a treatment response; in most cases, an underlying reason can be found. An assessment of risk of future severe asthma attacks, side-effects of medication and impaired lung development is also important. True severe, therapy-resistant asthma is rare and there are multiple underlying molecular pathologies. In HICs, steroid-resistant eosinophilia would be treated with omalizumab or mepolizumab, but the cost of these is prohibitive in LMICs, the biomarkers of successful therapy are likely only relevant to HICs. In LMICs, a raised blood eosinophil count may be due to parasites, so treating asthma based on the blood eosinophil count may not be appropriate in these settings.<\/jats:p>","DOI":"10.1007\/s12098-021-03952-w","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:02:54Z","timestamp":1634893374000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Severe and Difficult Asthma: Diagnosis and Management\u2014Challenges for a Low-Resource Environment"],"prefix":"10.1007","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6756-9822","authenticated-orcid":false,"given":"Andrew","family":"Bush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"key":"3952_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343\u201373.","journal-title":"Eur Respir J"},{"key":"3952_CR2","unstructured":"National Review of Asthma Deaths. Why asthma still kills. In: Royal College of Physicians. 2014. Available at: https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/why\u2013asthma\u2013still\u2013kills. Accessed on 1 June 2021."},{"key":"3952_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jaci.2010.07.019","volume":"126","author":"J Bousquet","year":"2010","unstructured":"Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the world health organization consultation on severe asthma. J Allergy Clin Immunol. 2010;126:926\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"3952_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1183\/09031936.00127606","volume":"29","author":"MU Pereira","year":"2007","unstructured":"Pereira MU, Sly PD, Pitrez PM, et al. Nonatopic asthma is associated with helminth infections and bronchiolitis in poor children. Eur Respir J. 2007;29:1154\u201360.","journal-title":"Eur Respir J"},{"key":"3952_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","volume":"391","author":"ID Pavord","year":"2018","unstructured":"Pavord ID, Beasley R, Agusti A, et al. After asthma - redefining airways diseases. Lancet. 2018;391:350\u2013400.","journal-title":"Lancet"},{"key":"3952_CR6","doi-asserted-by":"publisher","first-page":"00013","DOI":"10.1183\/23120541.00013-2018","volume":"4","author":"L Pembrey","year":"2018","unstructured":"Pembrey L, Barreto ML, Douwes J, et al. Understanding asthma phenotypes: the world asthma phenotypes (WASP) international collaboration. ERJ Open Res. 2018;4:00013\u20132018.","journal-title":"ERJ Open Res"},{"key":"3952_CR7","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S2213-2600(20)30399-4","volume":"8","author":"MW Pijnenburg","year":"2020","unstructured":"Pijnenburg MW, Fleming L. Advances in understanding and reducing the burden of severe asthma in children. Lancet Respir Med. 2020;8:1032\u201344.","journal-title":"Lancet Respir Med"},{"key":"3952_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S2213-2600(18)30513-7","volume":"7","author":"I Asher","year":"2019","unstructured":"Asher I, Bissell K, Chiang CY, et al. Calling time on asthma deaths in tropical regions\u2013how much longer must people wait for essential medicines? Lancet Respir Med. 2019;7:13\u20135.","journal-title":"Lancet Respir Med"},{"key":"3952_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1136\/thoraxjnl-2018-211626","volume":"73","author":"W Lenney","year":"2018","unstructured":"Lenney W, Bush A, Fitzgerald DA, et al. Improving the global diagnosis and management of asthma in children. Thorax. 2018;73:662\u20139.","journal-title":"Thorax"},{"key":"3952_CR10","doi-asserted-by":"crossref","unstructured":"Lemanske RF Jr, Mauger DT, Sorkness CA, et al; Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute. Step\u2013up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362:975\u201385.","DOI":"10.1056\/NEJMoa1001278"},{"key":"3952_CR11","doi-asserted-by":"crossref","unstructured":"Strunk RC, Bacharier LB, Phillips BR, et al; CARE Network. Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol. 2008;122:1138\u201344.","DOI":"10.1016\/j.jaci.2008.09.028"},{"key":"3952_CR12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(08)61448-8","volume":"372","author":"SJ Szefler","year":"2008","unstructured":"Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008;372:1065\u201372.","journal-title":"Lancet"},{"key":"3952_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1136\/adc.2008.152140","volume":"94","author":"M Bracken","year":"2009","unstructured":"Bracken M, Fleming L, Hall P, et al. The importance of nurse led home visits in the assessment of children with problematic asthma. Arch Dis Child. 2009;94:780\u20134.","journal-title":"Arch Dis Child"},{"key":"3952_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/thx.2005.042523","volume":"61","author":"CS Murray","year":"2006","unstructured":"Murray CS, Poletti G, Kebadze T, et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61:376\u201382.","journal-title":"Thorax"},{"key":"3952_CR15","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0140-6736(21)00458-X","volume":"397","author":"J Meghji","year":"2021","unstructured":"Meghji J, Mortimer K, Agusti A, et al. Improving lung health in low\u2013income and middle-income countries: from challenges to solutions. Lancet. 2021;397:928\u201340.","journal-title":"Lancet"},{"key":"3952_CR16","doi-asserted-by":"publisher","first-page":"1602221","DOI":"10.1183\/13993003.02221-2016","volume":"50","author":"T Halvorsen","year":"2017","unstructured":"Halvorsen T, Walsted ES, Bucca C, et al. Inducible laryngeal obstruction: an official joint European respiratory society and European laryngological society statement. Eur Respir J. 2017;50:1602221.","journal-title":"Eur Respir J"},{"key":"3952_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/thoraxjnl-2014-205738","volume":"70","author":"H Johansson","year":"2015","unstructured":"Johansson H, Norlander K, Berglund L, et al. Prevalence of exercise-induced bronchoconstriction and exercise-induced laryngeal obstruction in a general adolescent population. Thorax. 2015;70:57\u201363.","journal-title":"Thorax"},{"key":"3952_CR18","doi-asserted-by":"crossref","unstructured":"Peters MC, McGrath KW, Hawkins GA, et al; National Heart, Lung, and Blood Institute Severe Asthma Research Program. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross\u2013sectional analysis of two cohorts. Lancet Respir Med. 2016;4:574\u201384.","DOI":"10.1016\/S2213-2600(16)30048-0"},{"key":"3952_CR19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/rccm.201701-0082ED","volume":"195","author":"E Forno","year":"2017","unstructured":"Forno E, Weiner DJ, Mullen J, et al. Obesity and airway dsanapsis in children with and without asthma. Am J Respir Crit Care Med. 2017;195:314\u201323.","journal-title":"Am J Respir Crit Care Med"},{"key":"3952_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S2213-2600(17)30379-X","volume":"5","author":"A Bush","year":"2017","unstructured":"Bush A, Saglani S, Fleming L. Severe asthma: looking beyond the amount of medication. Lancet Respir Med. 2017;5:844\u20136.","journal-title":"Lancet Respir Med"},{"key":"3952_CR21","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.jaci.2017.08.020","volume":"141","author":"JA Wisniewski","year":"2018","unstructured":"Wisniewski JA, Muehling LM, Eccles JD, et al. TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status. J Allergy Clin Immunol. 2018;141:2048\u201360.","journal-title":"J Allergy Clin Immunol"},{"key":"3952_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jaci.2012.01.059","volume":"129","author":"C Bossley","year":"2012","unstructured":"Bossley C, Fleming L, Gupta A, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. J Allergy Clin Immunol. 2012;129:974\u201382.","journal-title":"J Allergy Clin Immunol"},{"key":"3952_CR23","doi-asserted-by":"publisher","first-page":"1900588","DOI":"10.1183\/13993003.00588-2019","volume":"55","author":"F Holguin","year":"2020","unstructured":"Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European respiratory society\/American thoracic society guideline. Eur Respir J. 2020;55:1900588.","journal-title":"Eur Respir J"},{"key":"3952_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1165\/rcmb.2021-0083ED","volume":"64","author":"CM Evans","year":"2021","unstructured":"Evans CM, McCubbrey AL. Can eosinophils prevent lung injury? ask PHIL. Am J Respir Cell Mol Biol. 2021;64:523\u20134.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3952_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ni.1981","volume":"12","author":"VT Chu","year":"2011","unstructured":"Chu VT, Fr\u00f6hlich A, Steinhauser G, et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol. 2011;12:151\u20139.","journal-title":"Nat Immunol"},{"key":"3952_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/adc.87.6.457","volume":"87","author":"GR Todd","year":"2002","unstructured":"Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCance D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457\u201361.","journal-title":"Arch Dis Child"},{"key":"3952_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1136\/thoraxjnl-2013-203773","volume":"68","author":"I Sabroe","year":"2013","unstructured":"Sabroe I, Postma D, Heijink I, Dockrell DH. The yin and the yang of immunosuppression with inhaled corticosteroids. Thorax. 2013;68:1085\u20137.","journal-title":"Thorax"},{"key":"3952_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2021.05.006","author":"A Bush","year":"2021","unstructured":"Bush A. Impact of early life exposures on respiratory disease. Pediatr Respir Rev. 2021. https:\/\/doi.org\/10.1016\/j.prrv.2021.05.006.","journal-title":"Pediatr Respir Rev"},{"key":"3952_CR29","doi-asserted-by":"crossref","unstructured":"O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179:19\u201324.","DOI":"10.1164\/rccm.200807-1126OC"},{"key":"3952_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S2213-2600(17)30434-4","volume":"5","author":"A Agust\u00ed","year":"2017","unstructured":"Agust\u00ed A, Noell G, Brugada J, Faner R. Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017;5:935\u201345.","journal-title":"Lancet Respir Med"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-021-03952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-021-03952-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-021-03952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T12:33:04Z","timestamp":1641558784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-021-03952-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3952"],"URL":"https:\/\/doi.org\/10.1007\/s12098-021-03952-w","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"8 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}